IASLC News | IASLC

The IASLC Lung Cancer News (ILCN) is the IASLC's official news medium for thoracic oncology specialists around the globe. ILCN provides its international audience with timely and relevant lung cancer news on topics across specialties and interests, such as novel clinical trial design and statistics, overcoming barriers to NGS testing, tobacco control and smoking/vaping cessation, patient-driven research, patient communication and care delivery during COVID, and more. Only the IASLC—the only international association dedicated to the study of lung cancer—can bring you multidisciplinary nuanced perspectives on daily clinical conundrums and the latest novel research by the true experts in the field.

Featured

Evolving Standards of Care

Increasing Understanding about the Role Biosimilar Agents in Everyday Practice: A Q&A with Dr. Gary Lyman (Part 1 of 2)

Gary Lyman, MD, MPH

Dec 30, 2020

Growing Importance and Changing Dynamics: Social Media’s Ever-Changing Role in Thoracic Oncology

Howard (Jack) West, MD

Dec 07, 2020

Patient during respiratory therapy. Printed with patient permission.

Nursing & Allied Health

Adjusting Occupational and Physical Therapy Services for Patients With Lung Cancer During the COVID-19 Pandemic

Pippa Labuc, BSc OT

+more

Jan 04, 2021

Radiation Oncology

SBRT Versus Surgery in the COVID-19 Era: What Has Changed and What Hasn't?

Suresh Senan, MRCP, FRCR, PhD

Dec 30, 2020

Evolving Standards of Care

Impactful Multidisciplinary Care Not Out of Reach in Community Settings

Leah Lawrence

Jan 04, 2021

Meeting News

Statistical Design Flexibility Versus Optimism: The Example of KEYNOTE-604

Urania Dafni, ScD

+more

Jan 11, 2021

University of California, Davis, Thoracic Oncology Innovation Group to Again Host Latin American Oncologists for 3-Day Preceptorship

Dr. David Gandara

Oct 19, 2020

Cell-free RNA Affords Another Tool in Lung Cancer Diagnosis and Treatment Monitoring

Kara Nyberg, PhD

Oct 09, 2020

Supporting the Detection of Early-Stage Disease with Use of Biomarkers

Kara Nyberg, PhD

Oct 09, 2020

Leveraging ctDNA to Detect Minimal Residual Disease Following Surgery

Kara Nyberg, PhD

Oct 09, 2020

Evolving Standards of Care

Liquid Biopsy: The Key Weapon for Real-Time Monitoring of Patients With NSCLC

Christian Rolfo

+more

Jan 20, 2021

Research’s Race to Stop a Pandemic

Leah Lawrence

Jan 19, 2021

CT Findings of COVID-19 Pneumonia and Mimicking Diseases in Patients With Lung Cancer

Soon Ho Yoon, MD, PhD

+more

Dec 30, 2020

EGFR/ALK-Mutated NSCLC: Using Real-world Therapeutic Practices to Help Answer Real-world Therapeutic Questions

Shirish Gadgeel, MD

Dec 30, 2020

Increasing Understanding about the Role Biosimilar Agents in Everyday Practice: A Q&A with Dr. Gary Lyman (Part 1 of 2)

Gary Lyman, MD, MPH

Dec 30, 2020

Interstitial Lung Abnormality, Interstitial Lung Disease, and Lung Cancer

Hiroto Hatabu, MD, PhD, FACR

+more

Dec 21, 2020

Pembrolizumab Is Active in Lung Cancer Brain Metastases

Sarah B. Goldberg, MD

Dec 14, 2020

Using Tumor Radiomic Features To Predict NSCLC Chemotherapy Response

Michelle Hershman, MD

+more

Dec 08, 2020

Radiation Oncology

Questions Remain Following Long-Term Results of the Phase II SABR-COMET Trial

Ricardo Sales dos Santos MD, PhD

Nov 23, 2020

The Immune System: A New Organ at Risk in Lung Cancer Radiation Therapy?

Sibo Tian, MD

+more

Oct 26, 2020

Understanding the Promising Role of Stereotactic Ablative Radiotherapy in Treating Patients With Oligometastatic Disease

Arya Amini

+more

Oct 19, 2020

CardiacRadiation.Daly.Fig1 - IMRT Plan for Locally Advanced NSCLC

Cardiac Radiation Dose, Cardiac Events, and Survival in Locally Advanced NSCLC

Megan Daly

Oct 19, 2020

Industry News & Regulatory Approvals

Osimertinib Approved as Adjuvant Therapy for NSCLC with Certain EGFR Mutations

Dec 22, 2020

First Therapeutic Approval in 16 years for MPM

Oct 19, 2020

FDA Perspectives on the Use of Liquid Biopsy in NSCLC

Kara Nyberg, PhD

Oct 09, 2020

Funding Opportunities for Innovative Multidisciplinary Cancer Research Teams

Oct 05, 2020

Nursing & Allied Health

The Role of Nurse Navigators in Lung Cancer: Advocates, Sounding Boards, and Care Coordinators for Patients

Megan Roy, BSN, RN, OCN

Dec 14, 2020

Good Communication Strategies While Wearing PPE

Beth Sandy, CRNP

Oct 26, 2020

Doctor of Nursing Practice Project Aims to Educate Non-Oncology Providers About the Management of Immunotherapy AEs

Feb 11, 2020

The IASLC and the International Thoracic Oncology Nursing Forum: Celebrating Collaboration

May 26, 2019

Mentorship and Travel Awards for Nursing and Allied Health at WCLC 2018

Apr 04, 2019

Names and News

Leora Horn, MD, MSc, FRCPC

Dec 21, 2020

Marianne J. Davies, DNP, MSN, RN, APRN, CNS-BC, ACNP-BC, AOCNP

Dec 21, 2020

Alexander Drilon, MD

Dec 18, 2020

In Memorium: Tobacco-Control Innovator, Former President of Uruguay, Dr. Tabaré Vázquez Dies from Lung Cancer at 80

Dec 08, 2020

The Chen-Huang Center for EGFR-Mutant Lung Cancers Represents a ‘Concentrated and Focused Effort’ in Studying Th is Disease Subset

Aug 20, 2020

Anne-Marie Baird, BSc, PhD

Aug 20, 2020

Paul G. Kluetz, MD

Jun 23, 2020

Shirish Gadgeel, MD

Jun 23, 2020

Podcasts

Explore More

Howard (Jack) West, MD, and Tony Mok, MD

Throwback to WCLC 2019

Episode

47

Oct 05, 2020

Narjust Duma, MD, Jhanelle E. Gray, MD, and Clarissa Mathias, MD, PhD

Equity in Medicine

Episode

46

Oct 05, 2020

Tips and Tricks for Navigating IASLC WCLC

Episode

54

Jan 20, 2021

Press Releases

Explore More

Press release

Routine Thoracic Surgery Safe During COVID-19 Pandemic

Jan 20, 2021

Press release

Lung Ambition Alliance Welcomes Five New Companies as Project Partners

Oct 19, 2020

Press release

Navy Veteran Employs Survival Attitude to Help Other Patients with Lung Cancer

Oct 16, 2020

Press releases_2017 opening press conference

For The Media

If you are a member of the media looking for more information about an IASLC-related event or program, please reach out to our media contacts.

Contact Us

Communications Committee

Comprising 30 members from around the world and across all areas of lung cancer patient care, including advocacy, the Communications Committee is eager to spotlight IASLC's programs and resources, as well as engage with members about important topics.

Learn more